Abstract
To determine the prevalence of depression, to identify correlated factors for depression, and to explore the impact on the progression or survival of amyotrophic lateral sclerosis (ALS) by depression in a Chinese population. A total of 166 ALS patients were recruited. Diagnosis of depression disorders and the severity of depression were established by using the fourth diagnostic and statistical manual of mental disorders, Hamilton Depression Rating Scale-24 items (HDRS-24) and Beck Depression Inventory (BDI). Major depression was found in 15 patients (9.6 %). The multiple regression analysis showed that a lower ALS Functional Rating Scale-Revised (ALSFRS-R) score was correlated with increasing HDRS scores and BDI scores (P = 0.018 and P = 0.012). No significant difference in the median survival time between ALS patients with and without depression was revealed by Kaplan–Meier analysis (log-rank P = 0.282). Cox hazard model showed that the presence of depression in ALS was unrelated to the survival, while the severity of depression in ALS was correlated with the survival. The presence and severity of depression in ALS did not correlate with the progression of ALS. Major depression in ALS is uncommon. Depression evaluation should be given to ALS patients, especially those with lower ALSFRS-R score. The severity of depression may be associated with the survival; however, depression does not worse the progression of ALS.
Similar content being viewed by others
References
Strong MJ (2001) Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 28(4):283–298
Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688–1700
Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347(9013):1425–1431
Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6(11):994–1003
Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M (2011) Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 12(2):109–112
Oh H, Sin MK, Schepp KG, Choi-Kwon S (2012) Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs 37(3):136–144
Olsson Ozanne AG, Strang S, Persson LI (2011) Quality of life, anxiety and depression in ALS patients and their next of kin. J Clin Nurs 20(1–2):283–291
Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, Mitsumoto H (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65(1):62–67
Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ (2015) Depression and disease progression in amyotrophic lateral sclerosis: a comprehensive meta-regression analysis. J Health Psychol 20(8):1107–1128
McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H (2009) Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 80(10):1146–1149
Bocker FM, Seibold I, Neundorfer B (1990) Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 58(6):224–236
Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I (2011) Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler 12(4):297–302
Trail M, Nelson ND, Van JN, Appel SH, Lai EC (2003) A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 209(1–2):79–85
Hillemacher T, Grassel E, Tigges S, Bleich S, Neundorfer B, Kornhuber J, Hecht MJ (2004) Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 5(4):245–249
Körner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S (2015) Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol 15:84
Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H (2011) Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res 20(4):569–574
Lule D, Hacker S, Ludolph A, Birbaumer N, Kubler A (2008) Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int 105(23):397–403
Rabkin JG, Wagner GJ, Del Bene M (2000) Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 62(2):271–279
McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA (1994) Survival in amyotrophic lateral sclerosis. The role of psychological factors, Arch Neurol 51(1):17–23
Zimmerman M, McGlinchey JB, Young D, Chelminski I (2006) Diagnosing major depressive disorder I: a psychometric evaluation of the DSM-IV symptom criteria. J Nerv Ment Dis 194(3):158–163
Brooks BR, Miller RG, Swash M, Munsat TL, World Federation Neurology Res G (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Dis 1(5):293–299
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1–2):13–21
Group GLAS (2003) A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology 61(11):1503–1507
Moberg PJ, Lazarus LW, Mesholam RI, Bilker W, Chuy IL, Neyman I, Markvart V (2001) Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 9(1):35–40
Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34(3):1184–1186
Swinscow TD (1976) Statistics at square one: XVIII-Correlation. Br Med J 2(6037):680–681
Ganzini L, Johnston WS, Hoffman WF (1999) Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52(7):1434–1440
Kurt A, Nijboer F, Matuz T, Kubler A (2007) Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 21(4):279–291
Narrow WE, Rae DS, Robins LN, Regier DA (2002) Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys’ estimates. Arch Gen Psychiatry 59(2):115–123
Feinstein A, Feinstein K (2001) Depression associated with multiple sclerosis’. Looking beyond diagnosis to symptom expression. J Affect Disord 66(2–3):193–198
Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M (2005) Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 26(4):255–262
Frick E, Tyroller M, Panzer M (2007) Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl) 16(2):130–136
Averill AJ, Kasarskis EJ, Segerstrom SC (2007) Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8(4):243–254
McLeod JE, Clarke DM (2007) A review of psychosocial aspects of motor neurone disease. J Neurol Sci 258(1–2):4–10
Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC (2015) A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care 13(4):1019–1024
Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, Sartori A, Lazzarino de Lorenzo L, Eleopra R, Barbone R (2015) The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: a population-based cohort study. Neuroepidemiology 44(2):91–98
Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S (2013) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol 20(4):647–654
Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218–1226
Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 19(3):360–375
Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotrophic Lateral Scler Frontotemporal Degen 15(1–2):9–14
Acknowledgments
The authors thank the patients for their participation in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interests.
Additional information
Q. Wei and Z. Zheng contribute to this work equally.
Rights and permissions
About this article
Cite this article
Wei, Q., Zheng, Z., Guo, X. et al. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients. Neurol Sci 37, 557–563 (2016). https://doi.org/10.1007/s10072-015-2472-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2472-y